Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

NovoCure Limited - Ordinary Shares (NQ:NVCR)

18.20 +0.84 (+4.84%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 12, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about NovoCure Limited - Ordinary Shares

< Previous 1 2
...
12 13 14 15 16 17 18 19 Next >
Reconsidered Boom
The US markets tried to repeat the big rise from yesterday, and appears to have succeeded. 
Via Talk Markets
The First Day Of Summer And Prime Day
The bull is back in business today. 
Via Talk Markets
The Daily Biotech Pulse: Orphazyme Falters At FDA, Athira's CEO Placed On Temporary Leave, 5 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 17) 10x Genomics, Inc. (NASDAQ... 
Via Benzinga
Exposures Product Safety
Stocks That Hit 52-Week Highs On Thursday
This morning 94 companies set new 52-week highs. Things to Consider: NVIDIA (NASDAQ:NVDA) was the largest firm by market cap to set a new 52-week high. Deswell Industries... 
Via Benzinga
Two Rate Hikes In 2023
This afternoon our Fed chief Jerome Powell predicted there will be interest rate hikes faster than before. The news hit US stocks, gold, and bitcoin hard. 
Via Talk Markets
Topics Economy
Exposures Interest Rates
Novocure Initiates Usability Study for Flexible Torso Array
From Novocure
Via Business Wire
Continued Uncertainty
Fear of another Fukushima yesterday late in the market day led to a rush out of energy-related shares, which included many without any nuclear risk at all. 
Via Talk Markets
The Daily Biotech Pulse: AstraZeneca, Biogen Face Clinical Trial Disappointments, Novavax Studies Coronavirus-Flu Combo Vaccine, Decision Day For Takeda
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 14) Alkermes plc (NASDAQ: ALKS... 
Via Benzinga
Dreary Day
Another dreary day and a renewed boost for cryptocurrency - and away from the classic inflation hedge, gold. 
Via Talk Markets
Unheeding Markets
Today oil prices rose over $70. 
Via Talk Markets
Wednesday News And Catch-Up
Today the US market resumed its attempt to hit a new record for the S&P 500 and Nasdaq, but not the DJIA. 
Via Talk Markets
Topics Stocks
Exposures US Equities
Juvenile Investing Mob
Tech stocks did well in Europe but not in the US. The data are unconvincing. 
Via Talk Markets
3 Unstoppable Stocks That Can Leave Dogecoin in the Dust
These fundamentally strong stocks are much better bets than the over-hyped Dogecoin. 
Via The Motley Fool
2 Innovative Growth Stocks to Buy for June
Got cash? Consider these high-flying growth stocks. 
Via The Motley Fool
Sterling At Five-Year High
Today markets are mixed because of currency factors, with sterling bullishness against the dollar and the euro. 
Via Talk Markets
Novocure Announces Clinical Trial Collaboration with GT Medical Technologies to Evaluate Tumor Treating Fields Together with GammaTile® Therapy in Recurrent Glioblastoma
From Novocure
Via Business Wire
Better Mood Day
The US Treasury plans to require IRS reporting on US cryptocurrency trades of $10,000 and up to prevent tax evasion. 
Via Talk Markets
May Or May Not Happen
Another day, another drop. 
Via Talk Markets
Novocure Surges As FDA Allows A Six Months Shorter Lung Cancer Study
Novocure said Tuesday it could have the results of a pivotal lung cancer study six months sooner than expected, leading NVCR stock to pop. 
Via Investor's Business Daily
Exposures Product Safety
Novocure Gets FDA Approval For Reducing Sample Size For Late-Stage Pivotal LUNAR Lung Cancer Study
The FDA has approved Novocure Ltd's (NASDAQ: NVCR) Investigational Device Exemption (IDE) supplement, reducing the enrollment requirement for its LUNAR Phase 3... 
Via Benzinga
Exposures Product Safety
Novocure Announces FDA Approval of IDE Supplement for Phase 3 Pivotal LUNAR Trial of Tumor Treating Fields in Non-Small Cell Lung Cancer
From Novocure
Via Business Wire
Friday Of The Heavy Week
There is nothing like a pending weekend to push Wall Street into recuperation and this worked today 
Via Talk Markets
Could Novocure Be a Millionaire-Maker Stock?
It's a good stock, but it might struggle to make you rich overnight. 
Via The Motley Fool
Heavy Global Erosion
It is an everything-down day. Even the news is down because commenters are being careful. 
Via Talk Markets
Gold Up Four Days In A Row
The dollar is at a nearly 3 month low. 
Via Talk Markets
Calm Markets Day
Despite seriously disappointing April jobless numbers, markets are gaining all the same. 
Via Talk Markets
Finns and Danes
Stock markets are still uncertain whether to rise or fall after the Tuesday debacle. 
Via Talk Markets
Cramer Weighs In On Penn National Gaming, Palantir And More
On CNBC's "Mad Money Lightning Round," Jim Cramer said he happens to like Penn National Gaming, Inc (NASDAQ: PENN) very much and it deserves to trade higher. Alcoa (... 
Via Benzinga
Unusually Heavy Friday
Today is a heavy news day, which is unusual for a Friday. We start with the largest company's lamentable report, follow with another confusing result, then a hopeful drug company report, and finish... 
Via Talk Markets
Stock Market Rally Navigates Earnings From Apple, Tesla, Google, Facebook, Microsoft, Amazon
The stock market rally navigated earnings from Apple, Tesla and the other "big six" market cap companies. Many breakouts, but not all succeeded. 
Via Investor's Business Daily
< Previous 1 2
...
12 13 14 15 16 17 18 19 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.